
From survodutide titration to oral PCSK9 adherence and HF care models, AHA 2026 experts pointed to pharmacists as key to putting new data into practice.
Pharmacy Times attended the 2024 San Antonio Breast Cancer Symposium from December 10 to December 13.
This episode of Pharmacy Focus: Oncology Edition highlights key insights from the 2024 San Antonio Breast Cancer Symposium, covering new FDA-approved therapies, dose optimization strategies, and innovative prevention approaches in breast cancer care.




